By attaching specialised molecules to the backbone of DNA, researchers have made it easier to detect rare molecules associated with early disease.
The presence of, or changes in the concentration of, certain proteins in biological fluids can be indicators of disease. However, in the early stages of disease these ‘biomarkers’ can be difficult to detect, as they are relatively rare.
We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.
– Dr Alex Ivanov
Detecting important biomarkers in lower concentrations will allow patients to be treated earlier for diseases such as some cancers and neurological disorders, which could increase the chance of survival rate.
However, current methods of detection are often not sufficiently sensitive and require costly and time-consuming sample pre-treatment.
Now, researchers from the Department of Chemistry at Imperial College London have come up with a system that is specific, flexible, and can detect single protein biomarkers directly in human serum (a pool of fluid separated from blood).
The system represents a significant innovation, as it is more sensitive to specific biomarkers and does not require clinical sample preparation. The method is published in Nature Communications.
Dr Alex Ivanov, co-leader of this study from the Department of Chemistry at Imperial, said: “The detection of single molecules of biomarkers represents the ultimate in sensitivity for early diagnosis. We have now shown that this is possible to perform such measurements in real human samples, opening up the potential for meaningful early diagnosis.”
Binding to biomarkers
The method the team developed uses the ‘backbone’ of DNA, the structure it is built around. They grafted ‘aptamers’ – synthetic DNA molecules that bind to specific target biomarkers – to DNA backbones.
When added to human serum, the aptamers bind to biomarkers before being analysed by passing through a nanopore detector. Nanopores are miniscule holes (often as small as a few billionths of a meter) that measure a change in electrical current as molecules pass through them.
Each biomarker has a unique current signature, so the presence and concentration of target biomarkers can be analysed in this way.
With the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
– Dr Jasmine Sze
The team demonstrated that their system can work by testing three aptamers on one DNA backbone. They found that the nanopores can detect the specific biomarkers that the aptamers were designed to pick up.
They say that the system can be constructed with more than five different aptamers, allowing detection of multiple biomarkers at once. In addition, the biomarkers were detected in human serum, meaning far less preparation time and cost were needed.
Based on the preliminary findings of this study, research efforts are now focused on several types of cancer and neurological disorders, which can benefit from the detection of biomarkers that are in low abundance in clinical samples.
The team have filed a patent for the technology, and are currently exploring routes towards commercialisation so that it can be used to ultimately improve quality of life.
Dr Jasmine Sze, who completed this study as part of her PhD in the Department of Chemistry and has recently moved to the IMED Biotech at AstraZeneca said “Looking forward, with the rapid growth in nanotechnology and nanopore technology, this innovative platform could pave the way for the next wave of clinical applications.
“It has great potential for biomarker discovery, development of companion diagnostics as well as clinical endeavours, such as direct diagnosis, prognosis and sub-type classification with single-molecule sensitivity.”
The Latest on: Disease diagnosis
- ESPN College Basketball Announcer Dick Vitale Announces His Lymphoma Diagnosison October 18, 2021 at 4:28 pm
ESPN college basketball announcer Dick Vitale (82) revealed he was diagnosed with lymphoma after being diagnosed and treated for melanoma this summer. After several tests over the past few weeks, ...
- New York City Hit by Spike of a Rare Disease Spread by Rat Urineon October 18, 2021 at 3:25 pm
So far, 15 cases of leptospirosis have reported in the city this year, with 13 people hospitalized and one dead.
- How interventional cardiology can help complex heart disease patientson October 18, 2021 at 1:09 pm
Overlake’s Complex Coronary Therapeutics Program is accepting new patients who may have been given few or no treatment options. Sponsored by Overlake.
- Parkinson’s disease symptoms: Five early indications of the condition that occur at nighton October 18, 2021 at 12:36 pm
PARKINSON'S disease is a condition whereby dopaminergic neurons that create dopamine, and are essential to movement, are depleted in the substantial nigra part of the brain.
- Pediatric Lyme Disease—'An Epidemic Within a Pandemic!’—to be Focus of Free Webinar Hosted by Quidel Corporation Oct. 21on October 18, 2021 at 11:56 am
Among the many health challenges facing children is the very real threat of contracting Lyme disease as nearly 30% of the estimated 476,000 people in the U.S. each year who are diagnosed and ...
- Jason Watkins: The star's 'painful' loss due to deadly disease - symptoms to be aware ofon October 18, 2021 at 11:30 am
JASON WATKINS has been the lead role in many TV dramas. His acting ability has led him to win many awards, and to the joys of viewers Jason is back in a new BBC drama starting tonight (October 18).
- Why are Gulf Coast welders dying from an anthrax-like disease?on October 18, 2021 at 9:30 am
(HealthDay)—A common group of bacteria may be causing deadly pneumonia or anthrax-like disease among metalworkers in the southern United States, health officials report.
- Tyrvaya nasal spray receives FDA approval for treatment of dry eye diseaseon October 18, 2021 at 7:34 am
The FDA approved Tyrvaya nasal spray for the treatment of signs and symptoms of dry eye disease, according to a press release from Oyster Point Pharma.Tyrvaya (varenicline solution 0.03 mg), formerly ...
- Be Careful Of Flu Symptoms If You Are Suffering From A Heart Disease, Can Turn Out To Be Fatalon October 18, 2021 at 7:03 am
People with flu are six times more likely to suffer from a heart attack or stroke, but a flu vaccine may be able to lower that risk. Here's how! TheHealthSite.com ...
- Early diagnosis with triple assessment is a cure to breast cancer: Experton October 18, 2021 at 5:57 am
Experts are unanimous that early diagnosis is essential to cure breast cancer. Cancer has been a menace to society since time immemorial, with people suffering severely all over t ...
via Google News and Bing News